NCT01297179

A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill

A Double-blind Two-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics (PK) of an Ethinyl Estradiol and Levonorgestrel Containing Combined Oral Contraceptive (COC)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to determine the effect of multiple doses of mirabegron on the pharmacokinetics of an oral contraceptive.

Conditions

• Healthy Volunteers
• Pharmacokinetics of Mirabegron

Interventions

Type	Name	Description
DRUG	Mirabegron	Oral
DRUG	Minidril	Oral
DRUG	Placebo	Oral

Timeline

• Start date: 2008-10-01
• Primary completion: 2009-03-01
• Completion: 2009-03-01
• First posted: 2011-02-16
• Last updated: 2013-07-03

Locations

1 site across 1 country: France